PEREGRINE PHARMACEUTICALS INC·4

Nov 1, 8:02 PM ET

PEREGRINE PHARMACEUTICALS INC 4

4 · PEREGRINE PHARMACEUTICALS INC · Filed Nov 1, 2016

Insider Transaction Report

Form 4
Period: 2016-10-31
KING STEVEN W
DirectorPresident & CEO
Transactions
  • Other

    Common Stock

    2016-10-31$0.29/sh+18,826$5,392212,789 total
Footnotes (1)
  • [F1]Shares acquired under the issuer's employee stock purchase plan on October 31, 2016.

Documents

1 file
  • 4
    king_f4.xmlPrimary

    OWNERSHIP DOCUMENT